Salesforce and WPP-backed Domo, which emerged from stealth in 2015 with a $2bn valuation, has filed to go public in an attempt to secure capital and avoid having to reduce its business.

Neuronetics has filed for an $86.3m initial public offering on Nasdaq that will offer exits to corporates Pfizer, General Electric and Ascension.

The company will sell up to approximately 7.7 million shares priced at $22.8 to $28.7, valuing the Rocket Internet-backed business at $618m to $758m.

3P Learning held a 40% stake in Learnosity after having most recently invested $13.9m in 2016, but has now sold it to Battery Ventures.

The EMS-backed gene therapy developer has filed for an $86.3m offering having raised about the same amount in venture funding.

BridgeBio Pharma retains a majority stake in spinoff Eidos, which has raised $91m in funding in just over a year.

Myriad Genetics will pay $375m in cash and stock for genetic screening provider Counsyl, allowing Illumina Ventures to exit.

Baidu, Legend Holdings and Tencent are all in line to exit the used vehicle marketplace, which plans to go public in the US.

The Nan Fung-backed neurological disorder treatment developer has raised $135m in funding in the past two years.